To ask the Secretary of State for Health if he will make a statement on the amount of NHS money applied to menopause research.

I regret that it is not possible separately to identify the money devoted to the range of conditions associated with the menopause from the £225 million spent on medical research last year. However, my hon. Friend will be aware of the current work which includes a review of screening techniques for postmenopausal osteoporosis and an economic evaluation of the benefits of hormone replacement therapy.

I thank my hon. Friend for her reply. I understand that the Government are spending somewhat less than £500,000 in that area. Is my hon. Friend aware of the proceedings of the international menopause conference which point out that the number of deaths of women in the post-50 age group from heart attack and particularly stroke is twice as great as the number dying from osteoporosis and 10 times as great as the number of deaths from breast cancer? Does not that mean that we should be putting a great deal more money into such research or is it to remain the Cinderella of medicine for ever?

My hon. Friend identifies why it is difficult separately to identify the sums of money. As she says, associated conditions are heart attacks, strokes and cancer. About £1·5 billion is spent on health research each year. Our new research strategy ensures that we get the best possible value from that and, above all, apply the lessons. However, I can give my hon. Friend the undertaking that as long as she remains in the House such research will not be the Cinderella of the health service. There are a great number of excellent projects. Should my hon. Friend happen to be in the Cleveland area, I strongly urge her to go to the South Cleveland hospital to see the excellent work being undertaken there with a bone densitometer.

Is not the Minister aware that it has been known for some time that four times as many women as men suffer the chronic pain that comes from the loss of movement in and the fracture of hip joints?

Order. I am not an expert, but does that question have something to do with the menopause?

You, Mr. Speaker, betray the ignorance of men if you do not understand the relevance of my question. The research has been done for some time and the results have been known for some time, yet still the Government do nothing.

I am pleased that there has been a threefold increase in, for example, HRT prescriptions during the past 10 years. We fund to the tune of £1·9 million about 40 voluntary organisations which help spread the message about the importance of HRT and the prevention of osteoporosis. Our recent leaflet on women's health, which has been a remarkable success, also provides information. However, the hon. Gentleman is right. When the research has been evaluated and the screening survey has been completed we will be able to make even further progress in ensuring that the health service is dedicated to prevention as well as cure.